A5043832332- Computational Drug Discovery Methods
- Tuberculosis Research and Epidemiology
- vaccines and immunoinformatics approaches
- Genomics and Rare Diseases
- Pancreatitis Pathology and Treatment
- Diabetes Management and Research
- Acute Myeloid Leukemia Research
- Machine Learning in Bioinformatics
- Bioinformatics and Genomic Networks
- Neutropenia and Cancer Infections
- Cancer-related gene regulation
- Chronic Myeloid Leukemia Treatments
University of California Davis Medical Center
2023
University of North Carolina at Chapel Hill
2020-2021
Durham VA Medical Center
2020
The COVID-19 pandemic has catalyzed a widespread effort to identify drug candidates and biological targets of relevance SARS-COV-2 infection, which resulted in large numbers publications on this subject. We have built the Knowledge Extractor (COKE), web application extract, curate, annotate essential drug–target relationships from research literature COVID-19. SciBiteAI ontological tagging COVID Open Research Data set (CORD-19), repository scientific publications, was employed relationships....
Objective: The COVID-19 pandemic has catalyzed a widespread effort to identify drug candidates and biological targets of relevance SARS-COV-2 infection, which resulted in large numbers publications on this subject. We have built the CO VID-19 K nowledge E xtractor (COKE), web application extract, curate, annotate essential drug-target relationships from research literature assist repurposing efforts. Materials Methods: SciBiteAI ontological tagging COVID Open Research Dataset (CORD-19),...
INTRODUCTION: Pancreatic enzyme replacement therapy (PERT) is recommended for patients with exocrine pancreatic insufficiency (EPI). Prescribing information recommends pancrelipase to be dosed between 500 and 2500 units/kg/meal. Because PERT can expensive, prescriptions unindicated reasons and/or inappropriate doses lead unnecessary healthcare costs. Thus, we aimed characterize the prescribing practices of pancrealipase at a single veterans affairs medical center (VAMC) determine burden cost...
<p><b>Objective:</b> The COVID-19 pandemic has catalyzed a widespread effort to identify drug candidates and biological targets of relevance SARS-COV-2 infection, which resulted in large numbers publications on this subject. We have built the <b><u>CO</u></b>VID-19 <b><u>K</u></b>nowledge <b><u>E</u></b>xtractor (COKE), web application extract, curate, annotate essential drug-target relationships from...